angiotensin ii has been researched along with Aortic Diseases in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (11.63) | 18.7374 |
| 1990's | 5 (11.63) | 18.2507 |
| 2000's | 12 (27.91) | 29.6817 |
| 2010's | 21 (48.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Milewicz, DM; Prakash, SK | 1 |
| Lei, H; Li, J; Li, L; Liu, H; Yi, J | 1 |
| Brian, L; Crowley, SD; Freedman, NJ; Huang, TQ; McMahon, TJ; Miller, FJ; Nepliouev, I; Rudemiller, NP; Shenoy, SK; Stiber, JA; Wertman, V; Wu, JH; Zhang, L; Zhang, Z | 1 |
| Brandt, M; Daiber, A; Foretz, M; Jansen, T; Kalinovic, S; Keaney, JF; Kröller-Schön, S; Kvandová, M; Lagrange, J; Münzel, T; Oelze, M; Schönfelder, T; Schulz, E; Steven, S; Viollet, B; Wenzel, P | 1 |
| Golledge, J; Kinobe, R; Krishna, SM; Morton, SK; Moxon, JV; Phie, J | 1 |
| Chuma, M; Fujino, H; Fukushima, K; Goda, M; Horinouchi, Y; Ikeda, Y; Ikuto, R; Imanishi, M; Ishizawa, K; Izawa-Ishizawa, Y; Kondo, M; Murai, Y; Takechi, K; Tsuchiya, K; Zamami, Y | 1 |
| Avery, EG; Balogh, A; Bartolomaeus, H; Dechend, R; Eckardt, KU; Fielitz, J; Forslund, SK; Gollasch, M; Grandoch, M; Haase, N; Hering, L; Höges, S; Homann, S; Kempa, S; Kozhakhmetov, S; Kräker, K; Krannich, A; Kusche-Vihrog, K; Kushugulova, A; Maase, M; Markó, L; Müller, DN; Rump, LC; Stegbauer, J; Tsvetkov, D; Wilck, N; Wundersitz, S; Yakoub, M; Zhumadilov, Z | 1 |
| Huang, Y; Ji, Q; Lin, Y; Liu, H; Shi, Y; Wang, J; Xiao, T; Ye, J; Zhang, L | 1 |
| Choi, SY; Jeong, MH; Kassack, MU; Kee, HJ; Kee, SJ; Kim, GR; Kurz, T; Pflieger, M; Ryu, Y; Seok, YM; Sun, S | 1 |
| Hirata, Y; Ikutomi, M; Minami, Y; Morita, T; Nagai, R; Nakajima, T; Sahara, M; Sata, M | 1 |
| Chen, W; Harrison, DG; Kirabo, A; Madhur, MS; Saleh, MA; Thabet, SR; Trott, DW; Wu, J; Xiao, L | 1 |
| Aoki, T; Ikeda, S; Kadomatsu, K; Kikuchi, N; Kurosawa, R; Miyata, S; Mukherjee, R; Nogi, M; Numano, K; Omura, J; Otsuki, T; Satoh, K; Satoh, T; Shimokawa, H; Spinale, FG; Sugimura, K; Sunamura, S; Suzuki, K; Tatebe, S | 1 |
| Ahluwalia, A; Duchene, J; Hodgkinson, CP; Hu, Y; Kiechl, S; Laxton, RC; Leung, KY; López-Otín, C; Scotland, RS; Simpson, IA; Smith, K; Willeit, J; Xiao, Q; Xu, Q; Ye, S; Zhang, F; Zhang, Z | 1 |
| Aravindhan, K; Bernard, RE; Cornejo, CA; Goodman, KB; Gough, PJ; Hoang, B; Jucker, BM; Karr, H; Macphee, CH; Olzinski, AR; Qin, P; Ringenberg, MA; Sehon, CA; Turner, GH; Willette, RN | 1 |
| Ali, ZA; Anderson, JA; Ashley, EA; Chun, HJ; Cox, CM; Kojima, Y; Krieg, PA; Kundu, RK; Leeper, NJ; Quertermous, T | 1 |
| Casley, D; Gaspari, TA; Tesanovic, S; Vinh, A; Widdop, RE | 1 |
| Li, Y; Liu, N; Ren, L; Sheng, Z; Tang, R; Zhi, H | 1 |
| Blinder, Y; Chen, W; Funt, SA; Harrison, DG; Iwakura, Y; Li, L; Lob, HE; Madhur, MS; Quyyumi, AA; Rahman, A; Vinh, A | 1 |
| Bendall, JK; Carter, EE; Channon, KM; Crabtree, MJ; Douglas, G; Hale, AB; Tatham, AL | 1 |
| Caligiuri, G; Clement, M; Fornasa, G; Gaston, AT; Groyer, E; Guedj, K; Kaveri, SV; Khallou-Laschet, J; Michel, JB; Morvan, M; Nicoletti, A; Tedgui, A | 1 |
| Liu, L; Shi, GP | 1 |
| Cooper, ME; Du, XJ; Head, GA; Kiriazis, H; Nguyen-Huu, TP; Pickering, R; Thomas, MC; Tikellis, C; Tsorotes, D | 1 |
| Egashira, K; Hiasa, K; Inoue, S; Ishibashi, M; Kitamoto, S; Ni, W; Nishida, K; Takeshita, A; Usui, M; Zhao, Q | 1 |
| Aviram, M; Coleman, R; Hamoud, S; Hayek, T; Kaplan, M; Keidar, S; Pavlotzky, E | 1 |
| Cupesi, M; Gannon, J; Huang, H; Lee, RT; MacGillivray, C; Schulze, PC; Sylvan, JD; Yoshioka, J | 1 |
| Egashira, K; Hirouchi, Y; Inoue, S; Kitajima, S; Kitamoto, S; Kohjimoto, Y; Nakano, K; Usui, M | 1 |
| Albornoz, F; Brown, NJ; Crandall, DL; Elokdah, H; Fogo, AB; Griffin, JP; Vaughan, DE; Weisberg, AD | 1 |
| Cassis, LA; Daugherty, A; Inagami, T; Lu, H; Rateri, DL | 1 |
| Wang, YX | 1 |
| Catanzaro, DF; Catanzaro, SE; Chen, R; Dansky, HM; Hu, L; Zhou, Y | 1 |
| Ishizaka, N; Matsuzaki, G; Mori, I; Nagai, R; Ohno, M; Saito, K | 1 |
| Ayabe, N; Babaev, VR; Fazio, S; Fogo, AB; Ichikawa, I; Kon, V; Linton, MF; Motojima, M; Suganuma, E; Zuo, Y | 1 |
| Angell-James, JE; George, MJ; Peters, CJ | 1 |
| de Lasson, L; Hansen, HE; Juhl, B; Paaske, WP; Pedersen, EB | 1 |
| Abe, S; Kinukawa, N; Nakamura, M | 1 |
| Abassi, ZA; Gurbanov, K; Haramati, A; Hoffman, A; Mulroney, SE; Opgenorth, TJ; Potlog, C; Winaver, J | 1 |
| Kimura, M; Nakashima, M; Ohashi, K; Umemura, K | 1 |
| Aoka, Y; Aomi, S; Ishizuka, N; Kasanuki, H; Kawana, M; Koyanagi, H; Nagashima, H; Naruse, M; Ogawa, M; Sakomura, Y; Uto, K | 1 |
| Davis, JO; Freeman, RH | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D | 1 |
| Scheitlin, WA | 1 |
| Cain, MD; Catt, KJ; Cran, E; Zimmet, PZ | 1 |
| Ayres, SM; Giannelli, S; Gregory, JJ; Mueller, HS | 1 |
4 review(s) available for angiotensin ii and Aortic Diseases
| Article | Year |
|---|---|
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice.
Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cardiac Output, High; Cardiomegaly; Cardiovascular System; Enzyme Inhibitors; Estradiol; Hypercholesterolemia; Hyperglycemia; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Phenotype; Simvastatin | 2005 |
Mechanisms regulating renin release.
Topics: Aldosterone; Angiotensin II; Animals; Aortic Diseases; Blood Pressure; Brain; Calcium; Catecholamines; Chemoreceptor Cells; Dogs; Glomerular Filtration Rate; Heart Failure; Hemorrhage; Hormones; Humans; Hyponatremia; Ischemia; Juxtaglomerular Apparatus; Kidney; Kidney Tubules, Distal; Peptides; Potassium; Pressoreceptors; Rabbits; Receptors, Adrenergic; Renal Artery; Renal Artery Obstruction; Renin; Sodium; Sympathetic Nervous System | 1976 |
ACE-inhibitors and atherosclerosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Arteriosclerosis; Captopril; Cilazapril; Disease Models, Animal; Haplorhini; Hyperlipidemias; Lipid Metabolism; Peptidyl-Dipeptidase A; Pyridazines; Rabbits; Rats | 1992 |
[Renal-vascular hypertension].
Topics: Adolescent; Adult; Aged; Aneurysm; Angiotensin II; Animals; Aortic Diseases; Arteriovenous Fistula; Child; Embolism; Female; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Radioisotope Renography; Renal Artery; Renal Artery Obstruction; Thrombosis; Vascular Diseases | 1967 |
2 trial(s) available for angiotensin ii and Aortic Diseases
| Article | Year |
|---|---|
A randomised, clinical study of the effect of low-dose dopamine on central and renal haemodynamics in infrarenal aortic surgery.
Topics: Aged; Aldosterone; Angiotensin II; Aorta, Abdominal; Aortic Diseases; Arginine Vasopressin; Arteriosclerosis; Atrial Natriuretic Factor; Blood Vessel Prosthesis; Dopamine; Endothelins; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Male; Middle Aged; Potassium; Prospective Studies; Renal Plasma Flow, Effective; Sodium | 1995 |
Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan's syndrome.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aorta; Aortic Diseases; Apoptosis; Cell Count; Cells, Cultured; Culture Media, Serum-Free; Female; Humans; Imidazoles; Indoles; Male; Marfan Syndrome; Middle Aged; Muscle, Smooth, Vascular; Pyridines; ras Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Thiazepines; Tunica Media | 2001 |
37 other study(ies) available for angiotensin ii and Aortic Diseases
| Article | Year |
|---|---|
X Marks the Spot: The Profound Impact of Sex on Aortic Disease.
Topics: Angiotensin II; Aorta; Aortic Diseases; Complement System Proteins; Humans; Sex Chromosomes | 2018 |
Dose-Effect of Irbesartan on Cyclooxygenase-2 and Matrix Metalloproteinase-9 Expression in Rabbit Atherosclerosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Diseases; Atherosclerosis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Irbesartan; Lipids; Male; Matrix Metalloproteinase 9; NF-kappa B; Plaque, Atherosclerotic; Rabbits; Signal Transduction | 2018 |
Drebrin regulates angiotensin II-induced aortic remodelling.
Topics: Angiotensin II; Animals; Aorta; Aortic Diseases; Arterial Pressure; Cell Proliferation; Disease Models, Animal; Extracellular Matrix; HEK293 Cells; Humans; Hypertension; Inflammation Mediators; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Neuropeptides; Reactive Oxygen Species; Signal Transduction; Vascular Remodeling | 2018 |
α1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunction.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Aorta; Aortic Diseases; Cells, Cultured; Cytokines; Disease Models, Animal; Gene Deletion; Genetic Predisposition to Disease; Inflammation Mediators; Macrophages; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Phenotype; Signal Transduction; Vasodilation | 2018 |
A diet enriched with tree nuts reduces severity of atherosclerosis but not abdominal aneurysm in angiotensin II-infused apolipoprotein E deficient mice.
Topics: Angiotensin II; Animal Feed; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Aortic Diseases; Atherosclerosis; Brachiocephalic Trunk; Dilatation, Pathologic; Disease Models, Animal; Fatty Acids, Omega-3; Male; Mice, Knockout, ApoE; Nutritive Value; Nuts; Plaque, Atherosclerotic; Polyphenols; Severity of Illness Index; Time Factors | 2018 |
Xanthine Oxidase Inhibition by Febuxostat in Macrophages Suppresses Angiotensin II-Induced Aortic Fibrosis.
Topics: Actins; Adventitia; Angiotensin II; Animals; Aorta; Aortic Diseases; Disease Models, Animal; Febuxostat; Fibroblasts; Fibrosis; Gout Suppressants; Hypertension; Macrophages; Male; Mice, Inbred C57BL; Transforming Growth Factor beta1; Vascular Remodeling; Xanthine Oxidase | 2019 |
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Diseases; Arrhythmias, Cardiac; Arterial Pressure; Atherosclerosis; Cardiomegaly; Disease Models, Animal; Hypertension; Male; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Propionates; T-Lymphocytes, Regulatory; Th17 Cells | 2019 |
Sestrin2 increases in aortas and plasma from aortic dissection patients and alleviates angiotensin II-induced smooth muscle cell apoptosis via the Nrf2 pathway.
Topics: Angiotensin II; Aorta; Aortic Diseases; Aortic Dissection; Apoptosis; Biomarkers; Case-Control Studies; Cell Proliferation; Cells, Cultured; Female; Humans; Macrophages; Male; Middle Aged; Myocytes, Smooth Muscle; NF-E2-Related Factor 2; Nuclear Proteins; Oxidative Stress; Vasoconstrictor Agents | 2019 |
Histone deacetylase inhibitor LMK235 attenuates vascular constriction and aortic remodelling in hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aortic Diseases; Benzamides; Gene Expression Regulation; Histone Deacetylase Inhibitors; Hypertension; Male; Mice; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Vasoconstriction | 2019 |
Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Femoral Artery; Gene Deletion; Genetic Predisposition to Disease; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Peptidyl-Dipeptidase A; Phenotype; Plaque, Atherosclerotic; Protein Kinase Inhibitors; RNA Interference; Signal Transduction; Transfection; Vascular System Injuries | 2014 |
Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase.
Topics: Adoptive Transfer; Angiotensin II; Animals; Aortic Diseases; CD4 Antigens; CD8 Antigens; Cells, Cultured; Collagen; Disease Models, Animal; Elastin; Fibroblasts; Homeodomain Proteins; Hypertension; Inflammation; Interleukin-17; Male; Mice; Mice, Knockout; p38 Mitogen-Activated Protein Kinases; Stress, Mechanical; T-Lymphocytes; Vascular Stiffness; Vasculitis; Vasoconstrictor Agents | 2014 |
Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Topics: Angiotensin II; Animals; Animals, Newborn; Aortic Diseases; Basigin; Blood Proteins; Cells, Cultured; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibrosis; Heart Failure; Hypertrophy, Left Ventricular; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinases; Mechanotransduction, Cellular; Mice, Knockout; Myocardium; Myocytes, Cardiac; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2016 |
A role of matrix metalloproteinase-8 in atherosclerosis.
Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Carotid Artery Diseases; Collagen; Coronary Stenosis; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Gene Frequency; Genetic Predisposition to Disease; Humans; Leukocyte Rolling; Macrophages; Male; Matrix Metalloproteinase 8; Mice; Mice, Knockout; Polymorphism, Single Nucleotide; Prospective Studies; Severity of Illness Index; Vascular Cell Adhesion Molecule-1 | 2009 |
Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Contrast Media; Dextrans; Dietary Fats; Disease Models, Animal; Ferrosoferric Oxide; Humans; Immunohistochemistry; Infusion Pumps, Implantable; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Mice, Knockout; Mice, Transgenic; Naphthyridines; Peritonitis; Receptors, CCR2; Time Factors | 2010 |
Upregulation of the apelin-APJ pathway promotes neointima formation in the carotid ligation model in mouse.
Topics: Adipokines; Angiotensin II; Animals; Aortic Diseases; Apelin; Apelin Receptors; Apolipoproteins E; Carotid Artery Diseases; Carotid Artery, Common; Carrier Proteins; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Intercellular Signaling Peptides and Proteins; Ligation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Paracrine Communication; Rats; Receptors, G-Protein-Coupled; RNA, Messenger; Time Factors; Tunica Intima; Up-Regulation | 2010 |
Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Superoxides; Time Factors; Vasodilation; Vasodilator Agents | 2010 |
Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.
Topics: Angiotensin II; Animals; Aortic Diseases; Atherosclerosis; Blotting, Western; Cardiovascular Agents; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Hypercholesterolemia; Immunohistochemistry; Lipids; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Radioimmunoassay; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors | 2011 |
Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.
Topics: Aged; Angiotensin II; Animals; Antibodies, Neutralizing; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Cells, Cultured; Dendritic Cells; Dietary Fats; Disease Models, Animal; Female; Humans; Inflammation; Interferon-gamma; Interleukin-17; Ligation; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Nitric Oxide; Spleen; Superoxides; Time Factors | 2011 |
Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE⁻/⁻ mice.
Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Chemotaxis; Disease Models, Animal; Disease Progression; Endothelial Cells; Humans; Macrophages; Membrane Glycoproteins; Mice; Mice, Knockout; Mice, Transgenic; NADPH Oxidase 2; NADPH Oxidases; Signal Transduction; Superoxides; Time Factors; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2012 |
A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Aneurysm, Abdominal; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Chemotaxis, Leukocyte; Disease Models, Animal; Dose-Response Relationship, Drug; Lymphocyte Activation; Macrophage Activation; Male; Mice; Mice, Knockout; Peptides; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Antigen, T-Cell; T-Lymphocytes; Time Factors | 2012 |
CD31: beyond a marker for endothelial cells.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Aneurysm, Abdominal; Aortic Diseases; Atherosclerosis; Male; Peptides; Platelet Endothelial Cell Adhesion Molecule-1 | 2012 |
Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aortic Diseases; Apoptosis; Biomarkers; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Peptidyl-Dipeptidase A; Plaque, Atherosclerotic; Telemetry | 2012 |
Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Chemokine CCL2; Chemokines; Cytokines; Disease Progression; Gene Expression Regulation; Gene Targeting; Humans; Hyperlipoproteinemia Type II; Imidazoles; Inflammation; Inflammation Mediators; Injections, Intramuscular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Olmesartan Medoxomil; Random Allocation; Recombinant Fusion Proteins; Sequence Deletion; Single-Blind Method; Tetrazoles | 2004 |
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cell Line; Enzyme Induction; Eplerenone; Hormone Antagonists; Humans; Lipid Peroxidation; Lipoproteins, LDL; Losartan; Macrophages, Peritoneal; Membrane Proteins; Mice; Mice, Knockout; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Peptidyl-Dipeptidase A; Phosphoproteins; Protein Transport; Ramipril; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Superoxides | 2004 |
Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity.
Topics: Angiotensin II; Animals; Aortic Diseases; Cardiomegaly; Carrier Proteins; Cell Cycle Proteins; Cell Size; Cells, Cultured; Constriction, Pathologic; Disease Models, Animal; Genetic Vectors; Heart; Ligation; Male; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Phenylephrine; Random Allocation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Single-Blind Method; Stress, Mechanical; Thioredoxins; Transcriptional Activation | 2004 |
Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Aorta, Abdominal; Aortic Diseases; Arteriosclerosis; Catheterization; Chemokine CCL2; Chemotaxis; Cholesterol; Cytokines; Diet, Atherogenic; DNA, Complementary; Drug Evaluation, Preclinical; Genetic Therapy; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iliac Artery; Immunoglobulin G; Immunoglobulin M; Inflammation; Macaca fascicularis; Male; Peptidyl-Dipeptidase A; Phenotype; Pravastatin; Random Allocation; Renin; Transfection | 2004 |
Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
Topics: Acetates; Administration, Oral; Angiotensin II; Animals; Antigens, Differentiation; Aorta; Aortic Diseases; Blood Pressure; Chemokine CCL2; Collagen Type I; Collagen Type III; Drug Evaluation, Preclinical; Fibronectins; Fibrosis; Gene Expression Regulation; Glomerulosclerosis, Focal Segmental; Heart; Hypertrophy, Left Ventricular; Indoleacetic Acids; Indoles; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nephrectomy; Osteopontin; Plasminogen Activator Inhibitor 1; Random Allocation; RNA, Messenger; Sialoglycoproteins; Single-Blind Method; Sodium Chloride, Dietary | 2005 |
Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensin III; Angiotensinogen; Animals; Aortic Diseases; Arteriosclerosis; Chemokine CCL2; Chickens; Diet, Atherogenic; Female; Hypercholesterolemia; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, LDL; Renin-Angiotensin System; RNA, Messenger | 2004 |
Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Female; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Sinus of Valsalva | 2005 |
Iron chelation suppresses ferritin upregulation and attenuates vascular dysfunction in the aorta of angiotensin II-infused rats.
Topics: Aldehydes; Angiotensin II; Animals; Aorta; Aortic Diseases; Apoferritins; Chemokine CCL2; Deferoxamine; Ferritins; Heme Oxygenase-1; Hypertension; Iron; Iron Chelating Agents; Iron Overload; Iron-Dextran Complex; Male; Norepinephrine; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Transferrin; RNA, Messenger; Up-Regulation; Vasoconstrictor Agents; Vasodilation | 2005 |
Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Body Weight; Disease Progression; Elasticity; Female; Hydralazine; Lipids; Losartan; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Vasoconstrictor Agents | 2007 |
Baroreflex sensitivity in rabbits during the development of experimental renal hypertension and medial sclerosis.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Aortic Diseases; Arteriosclerosis; Blood Pressure; Dose-Response Relationship, Drug; Hypertension, Renal; Injections, Intravenous; Muscle, Smooth, Vascular; Phenylephrine; Pressoreceptors; Pulse; Rabbits; Reflex; Time Factors | 1980 |
Aortic medial necrosis with or without thrombosis in rabbits treated with Russell's viper venom and angiotensin II.
Topics: Angiotensin II; Animals; Aorta; Aortic Diseases; Blood Pressure; Daboia; Drug Synergism; Female; Hyperlipidemias; Male; Myocardial Infarction; Necrosis; Rabbits; Reference Values; Serotonin; Thrombosis; Tunica Media; Viper Venoms | 1997 |
Impaired nitric oxide-mediated renal vasodilation in rats with experimental heart failure: role of angiotensin II.
Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aortic Diseases; Arteriovenous Fistula; Enzyme Inhibitors; Heart Failure; Hemodynamics; Kidney; Male; Nitric Oxide; Nitric Oxide Synthase; Penicillamine; Rats; Rats, Wistar; Renal Circulation; S-Nitroso-N-Acetylpenicillamine; Vasodilation; Vasodilator Agents; Venae Cavae | 1997 |
Effect of ecadotril, a neutral endopeptidase inhibitor, on myocardial hypertrophy in the rat aortic insufficiency model.
Topics: Angiotensin II; Animals; Aortic Diseases; Blood Pressure; Cardiomegaly; Disease Models, Animal; Guanosine Monophosphate; Male; Protease Inhibitors; Rats; Rats, Wistar; Thiorphan | 1998 |
Blood angiotensin II levels of normal and hypertensive subjects.
Topics: Angiotensin II; Aortic Diseases; Arteries; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Nephrectomy; Radioimmunoassay; Veins | 1969 |
Systemic hemodynamic and myocardial metabolic effects of isoproterenol and angiotensin after open-heart surgery.
Topics: Angina Pectoris; Angiotensin II; Aortic Diseases; Cardiac Output; Cardiac Surgical Procedures; Follow-Up Studies; Heart Valve Diseases; Hemodynamics; Humans; Isoproterenol; Lactates; Myocardium; Pyruvates; Rheumatic Heart Disease; Vascular Resistance | 1970 |